Skip to main content
. 2021 Mar 29;11(2):20458940211000234. doi: 10.1177/20458940211000234

Fig. 4.

Fig. 4.

CircHIPK3 binding with miR-328-3p. (a) The expression level of miRNAs in PDGF-treated hPAECs was detected by qRT-PCR. (b) The expression level of miR-328-3p in hPAECs was downregulated after PDGF treatment. CircHIPK3 knockdown reversed this effect. (c) The putative binding sites between circHIPK3 and miR-328-3p and the mutant sites in circHIPK3-MUT reporter were displayed. (d) Luciferase activity was detected in 293T cells cotransfected with circHIPK3-WT or circHIPK3-MUT reporter and miR-328-3p mimics or miR-328-3p inhibitor. (e) RNA immunoprecipitation assays demonstrated that circHIPK3 was directly binding to miR-328-3p. Data were expressed as mean ± SD in three independent experiments. **P < 0.01, ***P < 0.001. PGDF: platelet-derived growth factor; hPAEC: human pulmonary artery endothelial cell; GADPH: glycerldehyde-3-phosphate dehydrogenase; NC: negative control; IgG: immunoglobulin.